Clinical trials
Phase 2 Supranuclear Palsy, Progressive trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2006 | 2 |
| 2008 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 4 |
| 2023 | 2 |
| 2024 | 2 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Unknown status | 4 |
| Terminated | 3 |
| Enrolling by invitation | 2 |
| Recruiting | 2 |
| Withdrawn | 1 |
| Not yet recruiting | 1 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Adam Boxer | 3 |
| AbbVie | 2 |
| GemVax & Kael | 2 |
| AlzProtect SAS | 1 |
| Biogen | 1 |
| Biojiva LLC | 1 |
| EmeraMed | 1 |
| Ferrer Internacional S.A. | 1 |
| German Parkinson Study Group (GPS) | 1 |
| Groupe Hospitalier Pitie-Salpetriere | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Supranuclear Palsy, Progressive | 22 |
| Corticobasal Degeneration | 3 |
| Multiple System Atrophy | 3 |
| Tauopathies | 3 |
| Frontotemporal Dementia | 2 |
| Dementia | 1 |
| Disease Progression | 1 |
| Fatigue | 1 |
| Frontotemporal Lobar Degeneration | 1 |
| Neurodegenerative Diseases | 1 |
Trials
Showing 51 to 22 of 22. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.